title: Ga-67 uptake in diethylstilbestrol-induced gynecomastia. Experience with six patients.
abstract: Six patients who had been treated with diethylstibestrol (DES) for prostatic cancer had symmetrical breast uptake of Ga-67. Of these patients, five proved to have DES-induced gynecomastia. The minimum dose and administration period of DES required for Ga-67 uptake in gynecomastia is discussed.
authors.affiliation: Department of Radiology, Tokyo Metropolitan Komagome Hospital, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Kosuda
authors.forename: S
authors.initials: S
authors.lastname: Kawahara
authors.forename: K
authors.initials: K
authors.lastname: Tamura
authors.forename: K
authors.initials: K
authors.lastname: Saito
authors.forename: A
authors.initials: A
authors.lastname: Kubo
authors.forename: S
authors.initials: S
authors.lastname: Hashimoto
mesh_terms: D000368:Aged; D001940:Breast / Q000000981:diagnostic imaging*; D002951:Citrates; D019343:Citric Acid; D004054:Diethylstilbestrol / Q000009:adverse effects* / Q000627:therapeutic use; D005708:Gallium; D005710:Gallium Radioisotopes; D006177:Gynecomastia / Q000139:chemically induced / Q000000981:diagnostic imaging*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy; D011877:Radionuclide Imaging
chemical_list: D002951:Citrates; D005710:Gallium Radioisotopes; D019343:Citric Acid; D004054:Diethylstilbestrol; D005708:Gallium